UK markets open in 6 hours 34 minutes

BioCardia, Inc. (BCDA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3940+0.0080 (+2.07%)
At close: 04:00PM EDT
0.3895 -0.00 (-1.14%)
After hours: 04:39PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.74M
Enterprise value 10.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.76
Price/book (mrq)10.67
Enterprise value/revenue 22.97
Enterprise value/EBITDA -0.95

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-80.40%
S&P500 52-week change 325.38%
52-week high 32.9200
52-week low 30.3200
50-day moving average 30.4050
200-day moving average 30.5436

Share statistics

Avg vol (3-month) 3346.31k
Avg vol (10-day) 3229.95k
Shares outstanding 526.87M
Implied shares outstanding 626.87M
Float 817.6M
% held by insiders 129.96%
% held by institutions 17.51%
Shares short (15 Apr 2024) 4271.17k
Short ratio (15 Apr 2024) 41.98
Short % of float (15 Apr 2024) 41.17%
Short % of shares outstanding (15 Apr 2024) 41.01%
Shares short (prior month 15 Mar 2024) 41.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 306 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-16,030.77%

Management effectiveness

Return on assets (ttm)-113.89%
Return on equity (ttm)-703.62%

Income statement

Revenue (ttm)477k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-87.70%
Gross profit (ttm)N/A
EBITDA -11.56M
Net income avi to common (ttm)-11.57M
Diluted EPS (ttm)-0.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.1M
Total cash per share (mrq)0.04
Total debt (mrq)1.31M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.41
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-9.97M
Levered free cash flow (ttm)-6.03M